Leyden Labs

90 employees

Biotech/Pharma

Series B · $336.0M

Open positions (1)

Team Size90

IndustryBiotech/Pharma

Total raised

$336.0M

Last stage

Series B

Investors

GV (Google Ventures)

Casdin Capital

ClavystBio

StandoutYBacked by Y Combinator · P26

“LeBron has an agent. Why don’t you?”

— Now you have one too.

Standout.

Leyden Labs | Biotech/Pharma | Standout | Standout

Polaris Partners

SoftBank Vision Fund 2

Jaap Goudsmit

Infectious disease scientist and former Chief Scientific Officer at Crucell; led the discovery of the CR9114 broadly-neutralizing influenza antibody.

Dinko Valerio

Biotech entrepreneur and former CEO of Crucell; also co-founded ProQR Therapeutics and Aescap Venture.

Koenraad Wiedhaup

Former McKinsey & Company partner; co-founded Leyden Labs in 2020 alongside Jaap Goudsmit, Ronald Brus, and Dinko Valerio.

No applications, no recruiter spam. Just the intro.

A few questions to make sure this role is the right shape for you. Two minutes.

I write the intro, send it to the founder, and handle the back-and-forth.

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.